Chronic kidney disease in older people with intellectual disability: Results of the HA-ID study

Research in Developmental Disabilities

Volumn 35, Issue 3, 2014, Pages 726-732

  de Winter, C F ^a,b   Echteld, M A ^a   Evenhuis, H M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Reinaerde ^*  (Netherlands)

Author keywords

Down syndrome; Intellectual disability; Kidney disease; Prevalence; Renal dysfunction

Indexed keywords

CREATININE; CYSTATIN C;

AGING; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; INTELLECTUAL IMPAIRMENT; KIDNEY FUNCTION; LONGEVITY; OBESITY; PREVALENCE; RISK FACTOR; SARCOPENIA;

DOWN SYNDROME; INTELLECTUAL DISABILITY; KIDNEY DISEASE; PREVALENCE; RENAL DYSFUNCTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; DOWN SYNDROME; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; POLYPHARMACY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SARCOPENIA;

EID: 84896394114     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2013.11.005     Document Type: Article

References (37)

1. Adorno M., Sikandar S., Mitra S.S., Kuo A., Di Robilant B.N., Haro-Acosta V., et al. Usp16 contributes to somatic stem-cell defects in Down's syndrome. Nature 2013, 501(7467):380-384.
2. Bastiaanse L.P., Hilgenkamp T.I., Echteld M.A., Evenhuis H.M. Prevalence and associated factors of sarcopenia in older adults with intellectual disabilities. Research in Developmental Disabilities 2012, 33(6):2004-2012.
3. Campos C., Guzman R., Lopez-Fernandez E., Casado A. Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome. Biochimica et Biophysica Acta 2011, 1812(7):760-768.
4. Coppus A.M., Fekkes D., Verhoeven W.M., Evenhuis H.M., van Duijn C.M. Neopterin and the risk of dementia in persons with Down syndrome. Neuroscience Letters 2009, 458(2):60-64.
5. Coppus A.M., Fekkes D., Verhoeven W.M., Tuinier S., van Duijn C.M. Plasma levels of nitric oxide related amino acids in demented subjects with Down syndrome are related to neopterin concentrations. Amino Acids 2010, 38(3):923-928.
6. Coppus A.M., Schuur M., Vergeer J., Janssens A.C., Oostra B.A., Verbeek M.M., et al. Plasma beta amyloid and the risk of Alzheimer's disease in Down syndrome. Neurobiology of Aging 2012, 33(9):1988-1994.
7. de Kuijper G., Hoekstra P., Visser F., Scholte F.A., Penning C., Evenhuis H. Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription. Journal of Intellectual Disability Research 2010, 54(7):659-667.
8. de Winter C.F., Bastiaanse L.P., Hilgenkamp T.I., Evenhuis H.M., Echteld M.A. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: Results of the HA-ID study. Research in Developmental Disabilities 2012, 33(6):1722-1731.
9. de Winter C.F., Bastiaanse L.P., Hilgenkamp T.I., Evenhuis H.M., Echteld M.A. Overweight and obesity in older people with intellectual disability. Research in Developmental Disabilities 2012, 33(2):398-405.
10. de Winter C.F., Bastiaanse L.P., Hilgenkamp T.I.M., Evenhuis H.M., Echteld M.A. Peripheral arterial disease in older people with intellectual disability using the ankle-brachial index: Results of the HA-ID study. Research in Developmental Disabilities 2013, 34(5):1663-1668.
11. Draheim C.C., Geijer J.R., Dengel D.R. Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. American Journal of Cardiology 2010, 106(10):1512-1516.
12. Gopinath B., Harris D.C., Wall J.R., Kifley A., Mitchell P. Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas 2013, 75(2):159-164.
13. Guzman R., Campos C., Lopez-Fernandez E., Casado A. Biomarkers of age effect on renal function in Down syndrome. Biomarkers 2011, 16(8):679-685.
14. Harper C.R., Jacobson T.A. Managing dyslipidemia in chronic kidney disease. Journal of the American College of Cardiology 2008, 51(25):2375-2384.
15. Head E., Doran E., Nistor M., Hill M., Schmitt F.A., Haier R.J., et al. Plasma amyloid-beta as a function of age, level of intellectual disability, and presence of dementia in Down syndrome. Journal of Alzheimers Disease 2011, 23(3):399-409.
16. Hermans, H., & Evenhuis, H.M. (2013). Multimorbidity in older adults with intellectual disabilities. Submitted for publication.
17. Hilgenkamp T.I., Bastiaanse L.P., Hermans H., Penning C., van Wijck R., Evenhuis H.M. Study healthy ageing and intellectual disabilities: Recruitment and design. Research in Developmental Disabilities 2011, 32(3):1097-1106.
18. Hilgenkamp T.I., Reis D., van Wijck R., Evenhuis H.M. Physical activity levels in older adults with intellectual disabilities are extremely low. Research in Developmental Disabilities 2011, 33(2):477-483.
19. Hilgenkamp T.I., van Wijck R., Evenhuis H.M. (Instrumental) activities of daily living in older adults with intellectual disabilities. Research in Developmental Disabilities 2011, 32(5):1977-1987.
20. Inker L.A., Schmid C.H., Tighiouart H., Eckfeldt J.H., Feldman H.I., Greene T., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. New England Journal of Medicine 2012, 367(1):20-29.
21. Kavousi M., Elias-Smale S., Rutten J.H., Leening M.J., Vliegenthart R., Verwoert G.C., et al. Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study. Annals of Internal Medicine 2012, 156(6):438-444.
22. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annals of Internal Medicine 2006, 145(4):247-254.
23. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009, 150(9):604-612.
24. Lin J.D., Lin L.P., Hsieh M., Lin P.Y. Preliminary findings of serum creatinine and estimated glomerular filtration rate (eGFR) in adolescents with intellectual disabilities. Research in Developmental Disabilities 2010, 31(6):1390-1397.
25. Malaga S., Pardo R., Malaga I., Orejas G., Fernandez-Toral J. Renal involvement in Down syndrome. Pediatric Nephrology 2005, 20(5):614-617.
26. Morris C.A. Williams Syndrome 1993, doi: NBK1249 [bookaccession].
27. National Kidney Foundation Frequently asked questions about GFR estimates 2011, National Kidney Foundation, New York.
28. Schupf N., Zigman W.B., Tang M.X., Pang D., Mayeux R., Mehta P., et al. Change in plasma Ass peptides and onset of dementia in adults with Down syndrome. Neurology 2010, 75(18):1639-1644.
29. Schurman S.J., Scheinman S.J. Inherited cerebrorenal syndromes. Nature Reviews. Nephrology 2009, 5(9):529-538.
30. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. New England Journal of Medicine 2005, 352(20):2049-2060.
31. Stevens L.A., Li S., Kurella Tamura M., Chen S.C., Vassalotti J.A., Norris K.C., et al. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: Risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). American Journal of Kidney Disease 2011, 57(3 Suppl 2):S9-S16.
32. van Blijderveen J.C., Straus S.M., Zietse R., Stricker B.H., Sturkenboom M.C., Verhamme K.M. A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. International Urology and Nephrology 2013, (Epub ahead of print).
33. Visser W.E., de Rijke Y.B., van Toor H., Visser T.J. Thyroid status in a large cohort of patients with mental retardation: The TOP-R (Thyroid Origin of Psychomotor Retardation) study. Clinical Endocrinology (Oxford) 2011, 75(3):395-401.
34. Wang Y.L., Shu K.H., Yang M.F., Yang W.C., Wu M.J., Lin T.M., et al. The impact of body weight management in chronic kidney disease patients with obesity. Journal of Renal Nutrition 2013, 23(5):372-379.
35. WMA World Medical Association Declaration of Helsinky, Ethical Principles for Medical Research Involving Human Subjects 2008, From http://www.wma.net/en/30publications/10policies/b3/.
36. Zaal R.J., van der Kaaij A.D., Evenhuis H.M., van den Bemt P.M. Prescription errors in older individuals with an intellectual disability: Prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study. Research in Developmental Disabilities 2013, 34(5):1656-1662.
37. Zigman W.B. Atypical aging in down syndrome. Developmental Disabilities Research Reviews 2013, 18(1):51-67.